CLINICAL CHARACTERISTICS AND QUALITY OF LIFE OF THAI MODERATE TO SEVERE PSORIASIS PATIENTS BEFORE INITIATING SECUKINUMAB: AN INTERIM ANALYSIS FROM PROMPT STUDY

被引：0
|
作者：
Wongpraparut, C. [1 ]
Tovanabutra, N. [2 ]
Laodheerasiri, S. [3 ]
Chakkavittumrong, P. [4 ]
Choonhakarn, C. [5 ]
Pattamadilok, B. [6 ]
Rattanakaemakorn, P. [7 ]
Sangob, N. [8 ]
Pongmesa, T. [9 ]
Asawanonda, P. [10 ]
机构：
[1] Siriraj Hosp, Bangkok, Thailand
[2] Chiang Mai Univ, Chiang Mai, Thailand
[3] Phramongkutklao Hosp, Bangkok, Thailand
[4] Thammasat Univ, Khlongluang, Pathum Tani, Thailand
[5] Khon Kaen Univ, Khon Kaen, Thailand
[6] Inst Dermatol, Bangkok, Thailand
[7] Ramathibodi Hosp, Bangkok, Thailand
[8] Novartis, Bangyai 12, Thailand
[9] Novartis, Bangkok, Thailand
[10] Chulalongkorn Univ, Bangkok, Thailand
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO112
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [1] Analysis of efficacy and safety of secukinumab in patients with moderate to severe psoriasis in clinical practice
    Banos Arevalo, Antonio jose
    Barranquero Fernandez, Alvaro
    Herrera Acosta, Enrique
    Suarez Perez, Jorge Alonso
    Gonzalez Saavedra, Jose Andres
    Herrera Ceballos, Enrique
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB43 - AB43
  • [2] Real-Life Data of Secukinumab in Patients with Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis: Patient Baseline Characteristics Data from the PROMPT Study
    Ploysyne Rattanakaemakorn
    Parawee Chevaisrakul
    Chanisada Wongpraparut
    Praveena Chiowchanwisawakit
    Napatra Tovanabutra
    Pimchanok Tantiwong
    Warayuwadee Amornpinyo
    Panlop Chakkavittumrong
    Punchong Hanvivadhanakul
    Sumapa Chaiamnuay
    Supapat Laodheerasiri
    Bensachee Pattamadilok
    Charoen Choonhakarn
    Ajanee Mahakkanukrauh
    Duangkamol Aiewruengsurat
    Siripan Sangmala
    Nisa Pretikul
    Kittiwan Sumethkul
    Panchalee Satpanich
    Metavee Boonsiri
    Naruemon Sangob
    Pravit Asawanonda
    Dermatology and Therapy, 2024, 14 (12) : 3229 - 3241
  • [3] Secukinumab Treatment of moderate to severe Plaque Psoriasis in the clinical Routine Care: Baseline Characteristics of Psoriasis Patients at the Beginning of the PROSPECT Study
    Korber, A.
    von Kiedrowski, R.
    Kraehn-Senftleben, G.
    Schwinn A
    Hagemeier, H. H.
    Bachhuber, T.
    Kasparek, T.
    Amon, U.
    Augustin, M.
    Thaci, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 137 - 138
  • [4] ADHERENCE AND PERSISTENCE AMONG US PATIENTS INITIATING SECUKINUMAB FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS
    Feldman, S. R.
    Zhao, Y.
    Gray, S.
    Montejano, L. B.
    Lin, F.
    Herrera, V
    VALUE IN HEALTH, 2017, 20 (05) : A159 - A159
  • [5] QUALITY OF LIFE IN MODERATE TO SEVERE PSORIASIS PATIENTS IN SPAIN
    Puig, L.
    Sanchez-Carazo, J. L.
    Dauden, E.
    Vanaclocha, F.
    Toribio, J.
    Pujol, R.
    Casado, M. A.
    Sabater, F. J.
    VALUE IN HEALTH, 2008, 11 (06) : A621 - A621
  • [6] Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study
    Crowley, Jeffrey J.
    Langley, Richard G.
    Gordon, Kenneth B.
    Pinter, Andreas
    Ferris, Laura K.
    Rubant, Simone
    Photowala, Huzefa
    Xue, Zhenyi
    Wu, Tianshuang
    Zhan, Tianyu
    Beeck, Stefan
    Shah, Megha
    Warren, Richard B.
    DERMATOLOGY AND THERAPY, 2022, 12 (02) : 561 - 575
  • [7] Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study
    Jeffrey J. Crowley
    Richard G. Langley
    Kenneth B. Gordon
    Andreas Pinter
    Laura K. Ferris
    Simone Rubant
    Huzefa Photowala
    Zhenyi Xue
    Tianshuang Wu
    Tianyu Zhan
    Stefan Beeck
    Megha Shah
    Richard B. Warren
    Dermatology and Therapy, 2022, 12 : 561 - 575
  • [8] Effectiveness and safety of secukinumab in patients with moderate-to-severe plaque psoriasis - a real life retrospective study
    Galica, Katarzyna
    Lesiak, Aleksandra
    Ciazynska, Magdalena
    Noweta, Marcin
    Bednarski, Igor
    Narbutt, Joanna
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2021, 38 (06): : 973 - 978
  • [9] Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis
    Feldman, Steven R.
    Green, Lawrence
    Kimball, Alexa B.
    Siu, Kimberly
    Zhao, Yang
    Herrera, Vivian
    Nyirady, Judit
    Alexis, Andrew F.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2017, 28 (08) : 716 - 721
  • [10] Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis
    Feldman, Steven
    Green, Lawrence
    Kimball, Alexa B.
    Siu, Kimberly
    Zhao, Yang
    Herrera, Vivian
    Alexis, Andrew
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB227 - AB227
12345